The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial.
about
The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The CECARI Study: Everolimus ( ...... Multicenter, Randomized Trial.
@en
type
label
The CECARI Study: Everolimus ( ...... Multicenter, Randomized Trial.
@en
prefLabel
The CECARI Study: Everolimus ( ...... Multicenter, Randomized Trial.
@en
P2093
P2860
P356
P1476
The CECARI Study: Everolimus ( ...... Multicenter, Randomized Trial.
@en
P2093
Ann Belmans
Bart Meyns
David Derthoo
Eric Nellessen
Gábor Vörös
Johan Vanhaecke
Michel De Pauw
Nathalie Duerinckx
Olivier Van Caenegem
Stefan Janssens
P2860
P304
P356
10.1155/2017/6347138
P577
2017-02-20T00:00:00Z